skip to main content
caption: Erika Sandoval, a nurse with the Seattle Visiting Nurse Association, administers a flu shot on Tuesday, October 22, 2019, at Concord International Elementary School in Seattle.
Enlarge Icon
Erika Sandoval, a nurse with the Seattle Visiting Nurse Association, administers a flu shot on Tuesday, October 22, 2019, at Concord International Elementary School in Seattle.
Credit: KUOW Photo/Megan Farmer

Updates: Covid-19 pandemic in Washington state

This post will be updated with information about the Covid-19 pandemic in Washington state. Scroll down for older information.

As of Tuesday, October 27, the Washington State Department of Health reports:

  • 2,337 Covid-19 related deaths; 104,027 confirmed cases (2.2% death rate among positive cases).
  • Compared to white people and Asian people, the rate of Covid cases is nearly three times higher for Black people, and nearly seven times higher for Latino/x people and Native Hawaiian and Pacific Islanders.


2 guards, 1 nurse test positive for Covid-19 at Tacoma’s immigrant detention center

4:00 p.m. -- The acting managing nurse at the Northwest ICE Processing Center (formally the Northwest Detention Center) has tested positive for coronavirus, according to court records.

Documents filed Tuesday state, "The IHSC [ICE Health Services Corps] employee is not believed to have been infectious or to have potentially exposed others to Covid-19 when last at the NWIPC. "

The staff member was asymptomatic and found out she was positive after being tested for an outside medical procedure. Two other guards contracted through the GEO Group have also tested positive, all within the last month.

Detainees and staff will not be quarantined or tested. So far, 16 detained immigrants have tested positive for the virus since the start of the outbreak. Read more here.

-- Esmy Jimenez

UW researchers studying app to detect viral outbreaks

1 p.m. -- University of Washington researchers are seeking participants to see how well a smartphone app can detect viral outbreaks as the Covid-19 pandemic continues and the flu season arrives.

Researchers are using an app called "HIPPOCRATIC" which stands for "Health and Injury Prediction and Prevention Using Complex Reasoning and Analytic Techniques Integrated on a Cellphone." The study already has about 5,500 participants, but researchers are aiming to get 25,000 people.

According to UW: "Participants answer daily questions about their mood, physical and social activity, and sleep, and allow the app to collect passive data from sensors on the phone. The goal of the two-year study is to develop algorithms that enable continuous, real-time assessment of individuals’ health by making use of data that is passively and unobtrusively captured by smartphone sensors..."

Patricia Areán is spearheading the study. Areán is a professor of psychiatry and behavioral sciences at the University of Washington School of Medicine.

“This is a huge opportunity for us to get a sense as to whether or not phones could basically become a personal screener for an illness,” Areán said, noting that smartphones provide an opportunity to include segments of the population that are not often participants in such studies.

"We still need to work harder to reach these communities,” Areán said. “Our hope is that by giving them the voice they so desperately need, identified early so that these communities no longer experience the extreme negative impacts of future outbreaks."

People interested in participating can find more information here.

-- Dyer Oxley

Covid-19 cases spiking throughout western Washington

9 a.m. -- The coronavirus case count continues to climb around the Northwest.

Health officials aim to have the rate of Covid-19 cases at 25 per 100,000 people, or fewer. The numbers over the past two weeks have been far above that goal:

  • Snohomish County: 121 cases per 100,000 people
  • Pierce County: 132 per 100,000
  • King County: 99 per 100,000 cases

But King County public health officials also note that the death rate associated with Covid-19 has either flattened or decreased over the past two weeks.

-- Angela King

2 officers at Tacoma detention center have now tested positive for Covid-19

7 a.m. -- Two officers at the Northwest Detention Center in Tacoma have now tested positive for the coronavirus within the last month.

They join 16 immigration detainees who were also infected.

Facility operator GEO Group says one of the officers is in isolation while the other has recovered and has returned to work.

[The coronavirus has hit the Northwest Detention Center in Tacoma - the region's main immigration detention facility.

The jail's private operator, Geo Group, says two officers have tested positive in the past month.

Immigration advocates say 16 detainees have also been infected.

Read more details here.

-- Angela King


Hydroxychloroquine does not prevent or cure Covid-19, study says

9 a.m. -- Hydroxychloroquine became a familiar drug early on in the Covid-19 pandemic -- mostly for confusion around it.

The anti-malaria drug was touted as a cure by President Trump, but medical experts doubted whether that was true. So researchers at the University of Washington put hydroxychloroquine to the test over the past few months.

The verdict: Nope.

“This is a rigorous large-scale randomized, controlled clinical trial proving whether or not hydroxychloroquine is effective in preventing COVID-19, adding to less rigorously controlled studies,” said lead researcher Dr. Ruanne Barnabas, associate professor of medicine and of global health at the UW School of Medicine. “The additional data we have today provides strong evidence that hydroxychloroquine offers no benefit in preventing people from developing COVID-19 with a 14-day treatment course.”

The study out of UW shows hydroxychloroquine does not prevent people from developing Covid-19. Researchers found those who had close contact with an infected person and took the medication were just as likely to get Covid-19.

The study also found no evidence that those who got hydroxychloroquine were less likely to develop symptoms when infected.

After the president hyped hydroxychloroquine as a means to fight the novel coronavirus, it was pushed for emergency use during the pandemic. But it lost its emergency use authorization in June over safety concerns.

-- Angela King and Dyer Oxley

Where to get a free flu shot

8 a.m. -- There are now more places in western Washington where you can get a free flu shot if you don't have insurance.

The state health Department is working with 14 Safeway stores in the region, including:

  • Auburn on Auburn Way
  • Kent on Washington
  • South Seattle on Rainier
  • Shoreline on Aurora
  • Everett on Broadway and Rucker

The new partnership with the state department of health also covers Safeways in Tacoma, Bellingham, and Bremerton.

Drive-thru flu shot clinics are ongoing at North Seattle College and Seattle Public Schools. But this is the last week they’re open.

Ahead of flu season, health officials are pushing for everyone to get vaccinated who can, especially as more hospital beds start to fill up with Covid-19 patients. Health experts are concerned that the fall/winter surge of Covid-19 cases will coincide will a rise in flu cases, further straining the health care system already under pressure.

-- Anna Boiko-Weyrauch


FDA approves first official treatment for Covid-19

9 a.m. -- While many different experimental treatments have been used in the past, the FDA has approved the first official treatment for Covid-19 patients.

Remdesivir is an antiviral drug that has been commonly mentioned around Covid-19 cases, and has long been looked to with hope in aiding the fight against Covid-19. It is also known by its brand name Veklury. On Thursday, the FDA gave it the official thumbs up for use with patients 12 years and older and when the patient requires hospitalization.

“The FDA is committed to expediting the development and availability of Covid-19 treatments during this unprecedented public health emergency,” said FDA Commissioner Stephen M. Hahn, M.D. “Today’s approval is supported by data from multiple clinical trials that the agency has rigorously assessed and represents an important scientific milestone in the Covid-19 pandemic. As part of the FDA’s Coronavirus Treatment Acceleration Program, the agency will to continue to help move new medical products to patients as soon as possible, while at the same time determining whether they are effective and if their benefits outweigh their risks.”

The remdesivir treatment is not a vaccine (which is aimed at preventing infection). Rather, it is meant to treat a patient after they have become infected and reduce the time it takes them to recover in the hospital.

The approval comes after the FDA conducted a benefit-risk assessment, as well as three randomized clinical trials with Covid-19 patients.

According to the FDA: "The median time to recovery from Covid-19 was 10 days for the Veklury group compared to 15 days for the placebo group, a statistically significant difference. Overall, the odds of clinical improvement at Day 15 were also statistically significantly higher in the Veklury group when compared to the placebo group."

Remdesivir has already been approved for use in India, Singapore, and Japan for Covid-19 cases. The drug was initially developed for use in hepatitis C cases, and has also been used against Ebola.

-- Dyer Oxley

Read previous updates here